Mu-Zon Wu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Mu-Zon Wu has a total of 176 co-authors. Here are the top co-authors by number of shared publications:
- Mei-Hwei Chang
Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan; Department of Pediatrics, National Taiwan University College of Medicine and Hospital, Taipei, Taiwan
6 shared publications - Chao-Yu Hsu
Department of Medical Imaging and Radiology, National Taiwan University College of Medicine and Hospital, Taipei City, Taiwan
5 shared publications Hey-Chi Hsu
5 shared publications- Tiffany Ting-Fang Shih
Department of Radiology, College of Medicine, National Taiwan University, Taipei, Taiwan
5 shared publications - Wen-Yu Tsai
Department of Pediatrics, National Taiwan University Hospital and College of Medicine, National Taiwan University, Taiwan
5 shared publications - Cheng-Ting Lee
Department of Pediatrics, National Taiwan University Hospital and College of Medicine, National Taiwan University, Taipei, Taiwan
4 shared publications
Latest Publications
- 24 June 2019
- Published by Wiley in American Journal of Medical Genetics Part A
- Vol. 179 (9) , 1878-1883
Mosaic paternal haploidy in a patient with pancreatoblastoma and Beckwith–Wiedemann spectrum
Pancreatoblastoma is a rare type of pancreatic cancer in children. Here, we describe a case in which Beckwith‐Wiedemann syndrome (BWS) was first suspected because of placental mesenchymal dysplasia. Although the baby did not show the stigmata characteristic of BWS or abnormal peripheral blood methylation, she developed a massive pancreatoblastoma 2 months later. She survived after partial excision of the tumor and chemotherapy. The methylation pattern of the pancreatoblastoma tissue was typical of BWS. Single nucleotide polymorphism (SNP) array analyzes revealed that the pancreatoblastoma tissue had genome‐wide loss of maternal alleles. Peripheral blood and nontumor pancreatic tissue showed normal biparental genomic contribution. Interphase fluorescence in situ hybridization analysis with centromeric probes for chromosomes 2 and 11 revealed haploid pancreatoblastoma cells, whereas the placental mesenchymal dysplasia tissue and nontumor pancreas tissue showed diploidy. SNP genotype analysis suggested the presence of mosaicism with the pancreatoblastoma tissue having a different paternal haplotype than that of the peripheral blood and nontumor pancreatic tissue. We report for the first time mosaic paternal haploidy associated with pancreatoblastoma. Babies with placental mesenchymal dysplasia, even those without a definitive diagnosis of BWS, need to be closely followed for the occurrence of embryonic tumors.
- 24 June 2019
- Published by Wiley in American Journal of Medical Genetics Part A
- Vol. 179 (9) , 1878-1883
Mosaic paternal haploidy in a patient with pancreatoblastoma and Beckwith–Wiedemann spectrum
Pancreatoblastoma is a rare type of pancreatic cancer in children. Here, we describe a case in which Beckwith‐Wiedemann syndrome (BWS) was first suspected because of placental mesenchymal dysplasia. Although the baby did not show the stigmata characteristic of BWS or abnormal peripheral blood methylation, she developed a massive pancreatoblastoma 2 months later. She survived after partial excision of the tumor and chemotherapy. The methylation pattern of the pancreatoblastoma tissue was typical of BWS. Single nucleotide polymorphism (SNP) array analyzes revealed that the pancreatoblastoma tissue had genome‐wide loss of maternal alleles. Peripheral blood and nontumor pancreatic tissue showed normal biparental genomic contribution. Interphase fluorescence in situ hybridization analysis with centromeric probes for chromosomes 2 and 11 revealed haploid pancreatoblastoma cells, whereas the placental mesenchymal dysplasia tissue and nontumor pancreas tissue showed diploidy. SNP genotype analysis suggested the presence of mosaicism with the pancreatoblastoma tissue having a different paternal haplotype than that of the peripheral blood and nontumor pancreatic tissue. We report for the first time mosaic paternal haploidy associated with pancreatoblastoma. Babies with placental mesenchymal dysplasia, even those without a definitive diagnosis of BWS, need to be closely followed for the occurrence of embryonic tumors.
- Open Access
- 14 July 2018
- Published by Elsevier in Journal of the Formosan Medical Association
- Vol. 118 (1) , 450-456
The spectrum of 45,X/46,XY mosaicism in Taiwanese children: The experience of a single center
- 14 July 2018
- Published by Elsevier in Journal of the Formosan Medical Association
- Vol. 118 (1) , 450-456
Open AccessThe spectrum of 45,X/46,XY mosaicism in Taiwanese children: The experience of a single center
- Open Access
- 1 February 2018
- Published by Wolters Kluwer Health in Medicine
- Vol. 97 (8) , e9899
Short tandem repeat analysis for confirmation of uterine non-gestational choriocarcinoma in a postmenopausal Taiwanese woman
Rare uterine choriocarcinoma can be differentiated gestational from nongestational choriocarcinoma by using short tandem repeats (STRs). A 56-year-old Taiwanese woman underwent staging surgery because of suspicion of high-grade endometrial cancer. The pathology-confirmed uterine tumor with syncytiotrophoblasts and decidual change of the endometrium was harvested. Uterine nongestational choriocarcinoma. The tumor specimen, the patient's blood, and her husband's blood were drawn for STRs analysis using polymerase chain reaction amplification kit. The genotype of the tumor cells was solely maternal and made the diagnosis of uterine nongestational choriocarcinoma. Adjuvant chemotherapy with etoposide, methotrexate, actinomycin D, cyclophosphamide, vincristine regimen achieved good response in the patient. The patient is now recurrence-free for 12 months. STRs aid precise classification of rare choriocarcinoma. We encourage using the method to analyze suspicious choriocarcinoma.
- 1 February 2018
- Published by Wolters Kluwer Health in Medicine
- Vol. 97 (8) , e9899
Open AccessShort tandem repeat analysis for confirmation of uterine non-gestational choriocarcinoma in a postmenopausal Taiwanese woman
Rare uterine choriocarcinoma can be differentiated gestational from nongestational choriocarcinoma by using short tandem repeats (STRs). A 56-year-old Taiwanese woman underwent staging surgery because of suspicion of high-grade endometrial cancer. The pathology-confirmed uterine tumor with syncytiotrophoblasts and decidual change of the endometrium was harvested. Uterine nongestational choriocarcinoma. The tumor specimen, the patient's blood, and her husband's blood were drawn for STRs analysis using polymerase chain reaction amplification kit. The genotype of the tumor cells was solely maternal and made the diagnosis of uterine nongestational choriocarcinoma. Adjuvant chemotherapy with etoposide, methotrexate, actinomycin D, cyclophosphamide, vincristine regimen achieved good response in the patient. The patient is now recurrence-free for 12 months. STRs aid precise classification of rare choriocarcinoma. We encourage using the method to analyze suspicious choriocarcinoma.
- Open Access
- 1 May 2016
- Published by Elsevier in Journal of the Formosan Medical Association
- Vol. 115 (5) , 306-310
Clinical characteristics and long-term outcome of Taiwanese children with congenital hyperinsulinism
- 1 May 2016
- Published by Elsevier in Journal of the Formosan Medical Association
- Vol. 115 (5) , 306-310
Open AccessClinical characteristics and long-term outcome of Taiwanese children with congenital hyperinsulinism
- 1 January 2015
- Published by SAGE Publications in Antiviral Therapy
- Vol. 20 (1) , 93-96
Can Leflunomide Play a Role in Cytomegalovirus Disease Prophylaxis besides its Antirheumatic Effects?
Leflunomide, a disease-modifying antirheumatic drug (DMARD), has shown effectiveness in many autoimmune disorders and can suppress cytomegalovirus (CMV) disease in humans. Thus, it is possible for leflunomide to play a role in CMV prophylaxis or preemptive therapy in high-risk patients in addition to its application as a DMARD for autoimmune disorders. We describe two adult patients who developed CMV disease after administration of low-dose leflunomide. One patient was successfully treated with an increasing leflunomide dosage, resulting in a long-term suppression of serum CMV viral load.
- 1 January 2015
- Published by SAGE Publications in Antiviral Therapy
- Vol. 20 (1) , 93-96
Can Leflunomide Play a Role in Cytomegalovirus Disease Prophylaxis besides its Antirheumatic Effects?
Leflunomide, a disease-modifying antirheumatic drug (DMARD), has shown effectiveness in many autoimmune disorders and can suppress cytomegalovirus (CMV) disease in humans. Thus, it is possible for leflunomide to play a role in CMV prophylaxis or preemptive therapy in high-risk patients in addition to its application as a DMARD for autoimmune disorders. We describe two adult patients who developed CMV disease after administration of low-dose leflunomide. One patient was successfully treated with an increasing leflunomide dosage, resulting in a long-term suppression of serum CMV viral load.
- 1 February 2014
- Published by Elsevier in Journal of the Formosan Medical Association
- Vol. 113 (2) , 102-105
Endocrine dysfunction in Taiwanese children with human chorionic gonadotropin-secreting germ cell tumors
- 1 February 2014
- Published by Elsevier in Journal of the Formosan Medical Association
- Vol. 113 (2) , 102-105
Endocrine dysfunction in Taiwanese children with human chorionic gonadotropin-secreting germ cell tumors
- 1 October 2013
- Published by Elsevier in Journal of the Formosan Medical Association
- Vol. 112 (10) , 616-620
Clinical characteristics of central diabetes insipidus in Taiwanese children
- 1 October 2013
- Published by Elsevier in Journal of the Formosan Medical Association
- Vol. 112 (10) , 616-620
Clinical characteristics of central diabetes insipidus in Taiwanese children
- 1 March 2013
- Published by Elsevier in Journal of the Formosan Medical Association
- Vol. 112 (3) , 171-172
Pediatric primary lymphoma of the pituitary stalk: A different disease entity from the adult form?
- 1 March 2013
- Published by Elsevier in Journal of the Formosan Medical Association
- Vol. 112 (3) , 171-172
Pediatric primary lymphoma of the pituitary stalk: A different disease entity from the adult form?
- Open Access
- 2 September 2011
- Published by Wolters Kluwer Health in Hepatology
- Vol. 55 (1) , 161-172
Persistent Elevation of Hepatocyte Growth Factor Activator Inhibitors in Cholangiopathies Affects Liver Fibrosis and Differentiation
Alteration of cell surface proteolysis has been proposed to play a role in liver fibrosis, a grave complication of biliary atresia (BA). In this study we investigated the roles of hepatocyte growth factor activator inhibitor (HAI)–1 and –2 in the progression of BA. The expression levels of HAI–1 and –2 were significantly increased in BA livers compared with those in neonatal hepatitis and correlated with disease progression. In BA livers, HAI–1 and –2 were coexpressed in cells involved in ductular reactions. In other selective cholangiopathies, ductular cells positive for HAI–1 or HAI–2 also increased in number. Inflammatory cytokines, growth factors, and bile acids differentially up–regulated expression of HAI–1 and –2 transcripts in fetal liver cells and this induction could be antagonized by a cyclooxygenase–2 inhibitor. Conditioned media from cell lines stably overexpressing HAI–1 or HAI–2 enhanced the fibrogenic activity of portal fibroblasts and stellate cells, suggesting that both proteins might be involved in liver fibrosis. Because HAI–1 and –2 colocalized in ductular reactions sharing similar features to those observed during normal liver development, we sought to investigate the role of HAI–1 and –2 in cholangiopathies by exploring their functions in fetal liver cells. Knockdown of HAI–1 or HAI–2 promoted bidirectional differentiation of hepatoblast–derived cells. In addition, we showed that the hepatocyte growth factor activator, mitogen–activated protein kinase kinase 1, and phosphatidylinositol 3–kinase signaling pathways were involved in hepatic differentiation enhanced by HAI–2 knockdown. Conclusion : HAI–1 and –2 are overexpressed in the liver in cholangiopathies with ductular reactions and are possibly involved in liver fibrosis and hepatic differentiation; they could be investigated as disease markers and potential therapeutic targets. (Hepatology 2012)
- 2 September 2011
- Published by Wolters Kluwer Health in Hepatology
- Vol. 55 (1) , 161-172
Open AccessPersistent Elevation of Hepatocyte Growth Factor Activator Inhibitors in Cholangiopathies Affects Liver Fibrosis and Differentiation
Alteration of cell surface proteolysis has been proposed to play a role in liver fibrosis, a grave complication of biliary atresia (BA). In this study we investigated the roles of hepatocyte growth factor activator inhibitor (HAI)–1 and –2 in the progression of BA. The expression levels of HAI–1 and –2 were significantly increased in BA livers compared with those in neonatal hepatitis and correlated with disease progression. In BA livers, HAI–1 and –2 were coexpressed in cells involved in ductular reactions. In other selective cholangiopathies, ductular cells positive for HAI–1 or HAI–2 also increased in number. Inflammatory cytokines, growth factors, and bile acids differentially up–regulated expression of HAI–1 and –2 transcripts in fetal liver cells and this induction could be antagonized by a cyclooxygenase–2 inhibitor. Conditioned media from cell lines stably overexpressing HAI–1 or HAI–2 enhanced the fibrogenic activity of portal fibroblasts and stellate cells, suggesting that both proteins might be involved in liver fibrosis. Because HAI–1 and –2 colocalized in ductular reactions sharing similar features to those observed during normal liver development, we sought to investigate the role of HAI–1 and –2 in cholangiopathies by exploring their functions in fetal liver cells. Knockdown of HAI–1 or HAI–2 promoted bidirectional differentiation of hepatoblast–derived cells. In addition, we showed that the hepatocyte growth factor activator, mitogen–activated protein kinase kinase 1, and phosphatidylinositol 3–kinase signaling pathways were involved in hepatic differentiation enhanced by HAI–2 knockdown. Conclusion : HAI–1 and –2 are overexpressed in the liver in cholangiopathies with ductular reactions and are possibly involved in liver fibrosis and hepatic differentiation; they could be investigated as disease markers and potential therapeutic targets. (Hepatology 2012)
- 31 October 2010
- Published by Elsevier in Pediatrics & Neonatology
- Vol. 51 (5) , 303-307
Cushing's Disease in Children: Report of Three Cases
- 31 October 2010
- Published by Elsevier in Pediatrics & Neonatology
- Vol. 51 (5) , 303-307
Cushing's Disease in Children: Report of Three Cases